Anticoagulant Clinical Trial
Official title:
Intérêt de la protéine S100β Dans Les Traumatismes Crâniens légers Sous Anti-Thrombotiques
Head trauma is a common injury in emergency department. Investigation to search for complication is guided by the clinical examination and the case history, such as taking anti-thrombotics. Cranial computed tomography (CCT) is the gold standard to investigate, and is mandatory in case of antithrombotic drugs. Recently, some biomarkers have proven their utility to rule-out mild head trauma without CCT in the general population. Among these biomarkers, S100β protein has been added in guidelines for mild head trauma. Some studies have found similar data in population taking anticoagulant or antiplatelet drugs. The investigators aim to prove medical utility of S100β protein in population under antithrombotics, by the reduction of CCT use. Then, The investigators hypothesize that the add of S100β protein reduces cost of health care in the management of head injury in that population.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04010955 -
Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON)
|
||
| Recruiting |
NCT04673695 -
A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344
|
Phase 1 | |
| Completed |
NCT03893591 -
A Prospective Study to Examine the Need to Adjust the Dose of Apixaban When Used in Atrial Fibrillation and Obesity
|
||
| Completed |
NCT03895502 -
Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Study
|
Phase 4 | |
| Completed |
NCT03154489 -
Effectiveness of a Multidisciplinary Medication Review With Follow-up for Patients Treated With Coumarin Anticoagulants in Primary Care
|
N/A | |
| Recruiting |
NCT06020560 -
Study of Low Molecular Weight Heparins
|
Phase 4 | |
| Not yet recruiting |
NCT05788913 -
Evaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Subcutaneous Administration
|
Phase 1 | |
| Not yet recruiting |
NCT05788900 -
Evaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Intravenous Administration
|
Phase 1 | |
| Terminated |
NCT03172546 -
Determinants of Oral Anticoagulants' Activity
|
||
| Not yet recruiting |
NCT04592822 -
A Single Dose Bioequivalence Study of WD-1602 Versus Pradaxa® in Healthy Subjects Under Fed Condition
|
Phase 1 | |
| Recruiting |
NCT03772457 -
Predictive Value of Infarction Volume on Hemorrhagic Transformation in Ischemic Stroke/TIA With Non-valve Atrial Fibrillation(NVAF) Patients Using Rivaroxaban
|
||
| Completed |
NCT03323320 -
Evaluation of Patient's Knowledge of Their NACO Treatment
|
N/A | |
| Recruiting |
NCT04257487 -
Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study)
|
Phase 3 | |
| Completed |
NCT04272723 -
Management of Venous Thromboembolism in France: a National Survey Among Vascular Medicine Physicians
|
||
| Recruiting |
NCT04867200 -
A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344 in Healthy Volunteers
|
Phase 1 |